推出Abiliti™ Overnight 近視管理夜間矯視隱形眼鏡
Abiliti™ Overnight 夜間矯視隱形眼鏡已於歐盟被批准用於控制近視，並經證明在 2 年期間將近視兒童的軸向伸長量平均減少了 0.28 mm*,1-4。這些隱形眼鏡在夜間配戴後，可以暫時重塑角膜5-8，使患者在配戴後的第二天日間能夠看清楚†,9。每隻鏡片都是因應對個孩子的獨特角膜形狀和處方而專門設計的10。Abiliti™ Overnight 夜間矯視隱形眼鏡有可幫助控制近視避免加深。
矯正方法：
角膜矯形隱形眼鏡透過重新分佈角膜中央的組織，達至中央部份變得扁平及中央周邊部份變得陡斜12
為什麼要使用 Abiliti™ Overnight 夜間隱形眼鏡治療近視？
FitAbiliti™ 鏡片驗配軟件
利用最新技術，使球度處方的首次驗配成功率達到約 90%，順規散光處方的首次驗配成功率達到約 95%‡,§,8,11,13
白天無需配戴眼鏡，享受輕鬆生活
與配戴單光鏡片相比，患者的視力相關生活品質顯著改善2
覆蓋散光範圍
獲准治療高達 2.50D 的角膜散光9
安全的舒適配戴
充分的角膜氧合帶來舒適、安全的配戴體驗，DK（透氧率）為 1829
作為 Abiliti™ 產品組合綜合治療方法的一部分，我們還將為眼科專業人士提供 FitAbiliti™ 鏡片驗配軟件：
這是一款方便易用的軟件，旨在簡化整個管理過程，幫助您驗配 Abiliti™ Overnight夜間隱形眼鏡並跟進患者的近視變化過程。
Abiliti™ 產品組合讓您有效掌控近視治療。
我們可以攜手共同控制近視，讓孩子健康成長。了解更多關於 Johnson & Johnson Vision 臨床近視管理方法的資訊。在此下載我們的實踐指南。
參考文獻
*.與配戴單光近視鏡片相比 ,總括而言，近視控制 0.18亳米的眼睛軸長相約於0.5D 或50度近視。
†.屈光度數減少高達 4.00D，散光減少高達 2.50D。 2.50D 的散光
‡.最終鏡片驗配由 眼科專業人士 決定 — 軟件用於幫助決策
§.最終鏡片驗配由 眼科專業人士 決定 — 軟件用於幫助決策
1. Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci [Internet]. 2012/09/13. 2012;53(11):7077– 85.
2. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez- Ortega R. Myopia control with orthokeratology contact lenses in Spain: A comparison of vision-related quality-of-life measures between orthokeratology contact lenses and single-vision spectacles. Eye & Contact Lens. 2013;39(2).
3. Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci [Internet]. 2013/09/05. 2013;54(10):6510–7.
4. Walline JJ, Robboy MW, Hilmantel G, Tarver ME, Afshari NA, Dhaliwal DK, Morse CL, Quinn CJ, Repka MX, Eydelman MB. Food and Drug Administration, American Academy of Ophthalmology, American Academy of Optometry, American Association for Pediatric Ophthalmology and Strabismus, American Optometric Association, American Society of Cataract and Refractive Surgery, and Contact Lens Association of Ophthalmologists Co- Sponsored Workshop: Controlling the Progression of Myopia: Contact Lenses and Future Medical Devices. Eye Contact Lens.
5. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez- Ortega R. Short-term changes in ocular biometry and refraction after discontinuation of long-term orthokeratology. Eye Contact Lens. 2014;40(2).
6. Cho P, Cheung SW. Discontinuation of orthokeratology on eyeball elongation (DOEE). Cont Lens Anterior Eye [Internet]. 2017/01/01. 2017;40(2):82–7.
7. Lau JK, Vincent SJ, Cheung SW, Cho P. The influence of orthokeratology compression factor on ocular higher-order aberrations. Clin Exp Optom. 2020 Jan; 103(1):123-128.
8. Wan K, Lau JK kit, Cheung SW, Cho P. Refractive and corneal responses of young myopic children to short-term orthokeratology treatment with different compression factors. Contact Lens Anterior Eye. 2020;43(1):65-72.
9. Data on File 2021. Menicon CE technical file.
10. Data on File 2021 Menicon Design History file.
11. Chan KY, Cheung SW, Cho P. Clinical performance of an orthokeratology lens fitted with the aid of a computer software in Chinese children. Cont Lens Anterior Eye. 2012;35(4):180-184. doi: 10.1016/j.clae.2012.01.
12. Vincent SJ, Cho P, Chan KY, Fadel D, Ghorbani-Mojarrad N, González-Méijome JM, Johnson L, Kang P, Michaud L, Simard P, Jones L. CLEAR - Orthokeratology. Cont Lens Anterior Eye. 2021 Apr;44(2):240-269.
13. Chen CC, Cheung SW, Cho P. Toric orthokeratology for highlyÚstigmatic children. Optom Vis Sci [Internet]. 2012/05/09.2012;89(6):849–55.
HKM20220216_004
†.屈光度數減少高達 4.00D，散光減少高達 2.50D。 2.50D 的散光
‡.最終鏡片驗配由 眼科專業人士 決定 — 軟件用於幫助決策
§.最終鏡片驗配由 眼科專業人士 決定 — 軟件用於幫助決策
2. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez- Ortega R. Myopia control with orthokeratology contact lenses in Spain: A comparison of vision-related quality-of-life measures between orthokeratology contact lenses and single-vision spectacles. Eye & Contact Lens. 2013;39(2).
3. Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci [Internet]. 2013/09/05. 2013;54(10):6510–7.
4. Walline JJ, Robboy MW, Hilmantel G, Tarver ME, Afshari NA, Dhaliwal DK, Morse CL, Quinn CJ, Repka MX, Eydelman MB. Food and Drug Administration, American Academy of Ophthalmology, American Academy of Optometry, American Association for Pediatric Ophthalmology and Strabismus, American Optometric Association, American Society of Cataract and Refractive Surgery, and Contact Lens Association of Ophthalmologists Co- Sponsored Workshop: Controlling the Progression of Myopia: Contact Lenses and Future Medical Devices. Eye Contact Lens.
5. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez- Ortega R. Short-term changes in ocular biometry and refraction after discontinuation of long-term orthokeratology. Eye Contact Lens. 2014;40(2).
6. Cho P, Cheung SW. Discontinuation of orthokeratology on eyeball elongation (DOEE). Cont Lens Anterior Eye [Internet]. 2017/01/01. 2017;40(2):82–7.
7. Lau JK, Vincent SJ, Cheung SW, Cho P. The influence of orthokeratology compression factor on ocular higher-order aberrations. Clin Exp Optom. 2020 Jan; 103(1):123-128.
8. Wan K, Lau JK kit, Cheung SW, Cho P. Refractive and corneal responses of young myopic children to short-term orthokeratology treatment with different compression factors. Contact Lens Anterior Eye. 2020;43(1):65-72.
9. Data on File 2021. Menicon CE technical file.
10. Data on File 2021 Menicon Design History file.
11. Chan KY, Cheung SW, Cho P. Clinical performance of an orthokeratology lens fitted with the aid of a computer software in Chinese children. Cont Lens Anterior Eye. 2012;35(4):180-184. doi: 10.1016/j.clae.2012.01.
12. Vincent SJ, Cho P, Chan KY, Fadel D, Ghorbani-Mojarrad N, González-Méijome JM, Johnson L, Kang P, Michaud L, Simard P, Jones L. CLEAR - Orthokeratology. Cont Lens Anterior Eye. 2021 Apr;44(2):240-269.
13. Chen CC, Cheung SW, Cho P. Toric orthokeratology for highlyÚstigmatic children. Optom Vis Sci [Internet]. 2012/05/09.2012;89(6):849–55.
參考文獻
